MoonLake Immunotherapeutics’ (MLTX) Buy Rating Reiterated at Needham & Company LLC
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $66.00 price objective on the stock. Needham & Company LLC’s price target suggests a potential upside of 78.43% from the company’s previous close. A number of […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $66.00 price objective on the stock. Needham & Company LLC’s price target suggests a potential upside of 78.43% from the company’s previous close. A number of […]
